Back to Journals » Clinical Ophthalmology » Volume 12

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Total article views   HTML views PDF downloads Totals
14,015 Dovepress* 12,278+ 1,631 13,909
PubMed Central* 1,737 534 2,271
Totals 14,015 2,165 16,180
*Since 2 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar